ABSTRACT Objective: To assess the 30-day unplanned readmission rate and its association with overlapping probable sarcopenia and malnutrition after major oncological surgery. Methods: A prospective bicentric observational cohort study performed with adult oncological patients undergoing major surgery. The primary outcome was unplanned readmission within 30 days after discharge and the association with probable sarcopenia and malnutrition. Nutritional status and probable sarcopenia were assessed just prior to surgery. Patients classified using subjective global assessment, as B and C were malnourished. Probable sarcopenia was defined using SARC-F (strength, assistance with walking, rise from a chair, climb stairs, falls) questionnaire ≥4 points and low HGS (handgrip strength) <27kg for males and <16kg for females. Results: Two hundred and thirty-eight patients (51.7% female) with a median age of 60 years were included. The 30-day readmission rate was 9.0% (n=20). Univariate analysis showed an association of malnutrition (odds ratio (OR) = 4.84; p=0.024) and probable sarcopenia (OR = 4.94; p=0.049) with 30-day readmission. Furthermore, when both conditions were present, the patient was almost nine times more likely to be readmitted (OR = 8.9; p=0.017). Multivariable logistic regression analysis showed that overlapping probable sarcopenia and malnutrition was an independent predictor of 30-day unplanned readmission (OR = 8.10, 95% confidence interval (95%CI) 1.20-0.55; p=0.032). Conclusion: The 30-day unplanned readmission rate was 9.0%, and the overlap of probable sarcopenia and malnutrition is an independent predictor for the 30-day unplanned readmission after major oncologic surgery. Objective 30day day surgery Methods 3 assessment malnourished SARCF SARC F strength, strength (strength walking chair stairs falls 4 ≥ handgrip 27kg kg 16kg females Results thirtyeight thirty eight 51.7% 517 51 7 (51.7 female 6 included 90 9 0 9.0 n=20. n20 n n=20 . 20 (n=20) odds OR 4.84 484 84 p=0.024 p0024 p 024 4.94 494 94 p=0.049 p0049 049 Furthermore present 8.9 89 8 p=0.017. p0017 p=0.017 017 p=0.017) 810 10 8.10 95 95%CI 95CI CI (95%CI 1.200.55 120055 1.20 0.55 1 55 1.20-0.55 p=0.032. p0032 p=0.032 032 p=0.032) Conclusion 51.7 5 (51. 9. n2 n=2 2 (n=20 4.8 48 p=0.02 p002 02 4.9 49 p=0.04 p004 04 8. p001 p=0.01 01 81 8.1 200 1.200.5 12005 120 1.2 055 0.5 1.20-0.5 p003 p=0.03 03 51. (51 n= (n=2 4. p=0.0 p00 1.200. 1200 12 1. 05 0. 1.20-0. (5 (n= p=0. p0 1.200 1.20-0 ( (n p=0 1.20- p=

RESUMO Objetivo: investigar o impacto de procedimentos cirúrgicos oncológicos na função muscular de pacientes com e sem risco nutricional. Métodos: estudo observacional realizado com pacientes oncológicos candidatos a operações de grande porte entre julho de 2018 a março de 2019 em Cuiabá, Mato Grosso, Brasil. Os pacientes foram avaliados no pré-operatório quanto ao risco nutricional pela Nutricional Risk Screening-2002 e avaliou-se a força de preensão palmar (FPP) tanto no pré- quanto no 2º e 5º dia de pós-operatório (PO). Resultados: Foram avaliados 92 pacientes, dos quais 55,4% eram homens e 44,6% mulheres, com média (DP) de idade de 64 (10,81) para pacientes com risco e 51 (12,99) para pacientes sem risco nutricional. A avaliação nutricional pré-operatória mostrou que 34,8% dos pacientes não tinham risco e 65,2% apresentavam risco nutricional. A FPP foi menor (p=0,008) no grupo com risco nutricional no pré-operatório. Em ambos os grupos houve queda significativa da FPP no 2º dia de PO. A queda da FPP do pré-operatório para o 2º dia de PO foi mais pronunciada em pacientes sem risco nutricional (p=0,039). Pacientes com risco nutricional apresentaram maior tempo de internação (p=0,049). Conclusão: O trauma cirúrgico acarreta perda da função muscular no PO precoce. Pacientes sem risco nutricional apresentam queda da força muscular mais expressiva após procedimentos cirúrgicos oncológicos do que aqueles com risco nutricional. Esses resultados servem como argumento bastante forte para a implementação da Pré-habilitação em todos os pacientes candidatos a operações oncológicas de grande porte.

ABSTRACT Objectives : to investigate the impact of oncological surgical procedures on the muscle function of patients with and without nutritional risk. Methods: cross-sectional study conducted with cancer patients undergoing major operations between July 2018 to March 2019 in Cuiabá, Mato Grosso, Brazil. Patients were assessed preoperatively for the nutritional risk by the Nutricional Risk Screening-2002, and handgrip strength (FPP) was assessed both on the pre- and 2nd and 5th postoperative days (PO). Results: 92 patients were evaluated, of whom 55.4% were men and 44.6% women, with a mean age (SD) of 64 (10.81) for patients at risk and 51 (12.99) for patients without nutritional risk. The preoperative nutritional risk evaluation indicated that 34.8% of the patients had no risk and 65.2% had a nutritional risk. The FPP was lower (p = 0.008) in the group with nutritional risk in the preoperative period. In both groups, there was a significant drop in FPP on the 2nd PO day. The preoperative FPP compared with the 2nd PO FPP was more pronounced in patients without nutritional risk (p = 0.039). Patients with nutritional risk had a longer hospital stay (p = 0.049). Conclusion: surgical trauma causes loss of muscle function in the early PO. Patients without nutritional risk have a more significant decrease in muscle strength after surgical oncological procedures than those with nutritional risk. These results may infer the need to implement pre-habilitation in all patients who will undergo major oncological procedures.

RESUMO Objetivo: avaliar o impacto da provável sarcopenia (PS) pré-operatória na sobrevida de pacientes oncológicos submetidos a operações de grande porte. Métodos: estudo bicêntrico de coorte prospectivo, realizado com pacientes oncológicos adultos, submetidos a operação de grande porte no Hospital de Câncer e na Santa Casa de Misericórdia em Cuiabá-MT. A variável principal foi a ocorrência de óbito pós-operatório. Coletou-se dados demográficos, clínicos e o diagnóstico de PS, definido pela presença de: 1) risco de sarcopenia pelo questionário SARC-F e 2) baixa força muscular (Kgf) mensurada pela dinamometria. Calculou-se a taxa de sobrevida acumulada para os pacientes com e sem PS pela curva de Kaplan-Meier. Aplicou-se o modelo de regressão de Cox uni e multivariado para avaliar a associação da mortalidade com covariáveis de confundimento investigadas. Resultados: participaram do estudo 220 pacientes com idade média (DP) de 58,7±14,0 anos, sendo 60,5% do sexo masculino. Quatorze (6,4%) pacientes foram considerados com PS. Os pacientes com PS apresentaram risco aumentado para a ocorrência de óbito (RR=5,35 IC95% 1,95-14,66; p=0,001) e para complicações infecciosas (RR=2,45 IC95% 1,12-5,33; p=0,036). A sobrevida média em 60 dias, foi menor para os pacientes com PS: 44 (IIQ=32-37) vs 58 (IIQ=56-59) dias (log rank <0,001). A regressão Multivariada de Cox, mostrou que a PS foi fator de risco independente (HR=5,8 IC95% 1,49-22,58; p=0,011) para a mortalidade. Conclusão: os pacientes com PS submetidos a operações oncológicas de grande porte apresentam menor probabilidade de sobrevida a curto prazo e a PS pré-operatória, é fator de risco independente para mortalidade pós-operatória.

ABSTRACT Objective: to evaluate the impact of probable sarcopenia (PS) on the survival of oncological patients submitted to major surgeries. Method: prospective cohort bicentrical study enrolling adult oncological patients submitted to major surgeries at Cancer Hospital and Santa Casa de Misericordia in Cuiabá-MT. The main endpoint was the verification of postoperative death. Demographic and clinical data was collected. PS was defined as the presence of 1) sarcopenia risk assessed by SARC-F questionnaire and 2) low muscle strength measured by dynamometry. The cumulative mortality rate was calculated for patients with either PS or non PS using Kaplan Meier curve. The univariate and multivariate Cox regression model was used to evaluate the association of mortality with various investigated confounding variables. Results: a total of 220 patients with a mean (SD) age of 58.7±14.0 years old, 60.5% males participated of the study. Patients with PS had higher risk to postoperative death (RR=5.35 95%CI 1.95-14.66; p=0,001) and for infectious complications (RR=2.45 95%CI 1.12-5.33; p=0.036). The 60 days mean survival was shorter for patients with PS: 44 (IQR=32-37) vs 58 (IQR=56-59) days (log rank <0,001). The Cox multivariate regression showed that PS was an independent risk factor (HR=5.8 95%CI 1.49-22.58; p=0.011) for mortality. Conclusion: patients bearing PS submitted to major oncological surgery have less probability of short term survival and preoperative PS is an independent risk for postoperative mortality.